The interplay between endoplasmic reticulum stress and inflammation

Immunology and Cell Biology

Volumn 90, Issue 3, 2012, Pages 260-270

  Hasnain, Sumaira Z ^a   Lourie, Rohan ^a,b   Das, Indrajit ^a,c   Chen, Alice C H ^a,b   McGuckin, Michael A ^a,b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

autoimmune disease; endoplasmic reticulum stress; inflammation; unfolded protein response

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTHROPATHY; AUTOIMMUNE DISEASE; AUTOPHAGY; BONE DISEASE; CONFERENCE PAPER; EFFECTOR CELL; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MUCOSAL DISEASE; NEUROMUSCULAR DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN FOLDING; UNFOLDED PROTEIN RESPONSE;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; STRESS, PHYSIOLOGICAL; UNFOLDED PROTEIN RESPONSE;

ANIMALIA;

EID: 84858699864     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.112     Document Type: Conference Paper

References (60)

1. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151. (Pubitemid 19090837)
2. Harley JB, Scofield RH. Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology. J Clin Immunol 1991; 11: 297-316.
3. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G et al. Determinant spreading: Lessons from animal models and human disease. Immunol Rev 1998; 164: 209-229. (Pubitemid 28438410)
4. Rhodes DA, Trowsdale J. TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol 2007; 44: 2406-2414. (Pubitemid 46099050)
5. Ottosson L, Hennig J, Espinosa A, Brauner S, Wahren-Herlenius M, Sunnerhagen M. Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome. Mol Immunol 2006; 43: 588-598. (Pubitemid 41785386)
6. Dugar M, Cox S, Limaye V, Gordon TP, Roberts-Thomson PJ. Diagnostic utility of anti- Ro52 detection in systemic autoimmunity. Postgrad Med J 2010; 86: 79-82.
7. Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 1998; 111: 365-371. (Pubitemid 28088319)
8. Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP et al. 60kD Ro and nRNP A frequently initiate human lupus autoimmunity. PLoS One 2010; 5: E9599.
9. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011; 13: R30.
10. Kelsoe G. B cell tolerance: Putting the horse before the cart. Arthritis Rheum 2011; 63: 1173-1176.
11. Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: Tools to study the regulation of the autoimmune response. J Autoimmun 2010; 35: 256-264.
12. Reed JH, Jackson MW, Gordon TP. B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens. J Autoimmun 2008; 31: 263-267.
13. Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci 2010; 1183: 267-287.
14. Buyon JP, Clancy RM. Maternal autoantibodies and congenital heart block: Mediators, markers, and therapeutic approach. Semin Arthritis Rheum 2003; 33: 140-154. (Pubitemid 38030078)
15. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835. (Pubitemid 32758230)
16. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003; 142: 678-683. (Pubitemid 36737172)
17. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al. Autoimmuneassociated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666. (Pubitemid 28273312)
18. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: A population-based study. Arthritis Rheum 2001; 44: 487-488.
19. Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM, Kim MY et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009; 60: 3091-3097.
20. Buyon JP, Clancy RM. Dying right to live longer: Positing apoptosis as a link between maternal autoantibodies and congenital heart block. Lupus 2008; 17: 86-90. (Pubitemid 351346440)
21. Karnabi E, Qu Y, Wadgaonkar R, Mancarella S, Yue Y, Chahine M et al. Congenital heart block: Identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel. J Autoimmun 2010; 34: 80-86.
22. Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A et al. Anti- 52kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004; 31: 2480-2487. (Pubitemid 39603101)
23. Salomonsson S, Dzikaite V, Zeffer E, Eliasson H, Ambrosi A, Bergman G et al. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immunol 2011; 74: 511-517.
24. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330. (Pubitemid 24091790)
25. Lawley W, Doherty A, Denniss S, Chauhan D, Pruijn G, van Venrooij WJ et al. Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology (Oxford) 2000; 39: 253-261. (Pubitemid 30204208)
26. Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: A possible mechanism in the pathogenesis of Sjogren's syndrome. Scand J Immunol 2002; 56: 456-469. (Pubitemid 35373682)
27. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151. (Pubitemid 19090837)
28. Reed JH, Neufing PJ, Jackson MW, Clancy RM, Macardle PJ, Buyon JP et al. Different temporal expression of immunodominant Ro60/60kDa-SSA and La/SSB apotopes. Clin Exp Immunol 2007; 148: 153-160. (Pubitemid 46364998)
29. Neufing PJ, Clancy RM, Jackson MW, Tran HB, Buyon JP, Gordon TP. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells. Arthritis Rheum 2005; 52: 3934-3942. (Pubitemid 41798233)
30. Clancy RM, Backer CB, Yin X, Chang MW, Cohen SR, Lee LA et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: Implications for pathogenesis. Arthritis Rheum 2004; 50: 2598-2603. (Pubitemid 39062721)
31. Clancy RM, Neufing PJ, Zheng P, O'Mahony M, Nimmerjahn F, Gordon TP et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006; 116: 2413-2422. (Pubitemid 44330140)
32. Briassouli P, Komissarova EV, Clancy RM, Buyon JP. Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block. Circ Res 2010; 107: 374-387.
33. Clancy RM, Askanase AD, Kapur RP, Chiopelas E, Azar N, Miranda-Carus ME et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody- mediated congenital heart block. J Immunol 2002; 169: 2156-2163. (Pubitemid 34857683)
34. Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J, Buyon JP. Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: A novel pathway to autoimmune-associated heart block. J Immunol 2010; 184: 2148-2155.
35. Alvarez D, Briassouli P, Clancy RM, Zavadil J, Reed JH, Abellar RG et al. A novel role of endothelin-1 in linking toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. J Biol Chem 2011; 286: 30444-30454.
36. Reed JH, Thurgood L, Gordon DL, Gordon TP. Differential activation of complement by apoptotic cells opsonized with anti-Ro60 and anti-La autoantibodies. Scand J Immunol 2010; 72: 260-261.
37. Reed JH, Jackson MW, Gordon TP. A B cell apotope of Ro 60 in systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1125-1129. (Pubitemid 351564015)
38. Reed JH, Giannakopoulos B, Jackson MW, Krilis SA, Gordon TP. Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells. Arthritis Rheum 2009; 60: 860-869.
39. Reed JH, Clancy RM, Purcell AW, Kim MY, Gordon TP, Buyon JP. beta2-glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus. J Immunol 2011; 187: 520-526.
40. Robertson SA, Roberts CT, van Beijering E, Pensa K, Sheng Y, Shi T et al. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Mol Hum Reprod 2004; 10: 409-416. (Pubitemid 38714373)
41. Waterman, SA, Jackson MW, Gordon TP. Functional effects of autoantibodies. In: Autoimmun Dis, (4th ed.) Elsevier Academic Press: Amsterdam, 2006, 217-234.
42. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000; 43: 1647-1654. (Pubitemid 30452487)
43. Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 2004; 126: 819-828. (Pubitemid 38298330)
44. Karnabi E, Boutjdir M. Role of calcium channels in congenital heart block. Scand J Immunol 2010; 72: 226-234.
45. Boutjdir M, Chen L, Zhang ZH, Tseng CE, DiDonato F, Rashbaum W et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80: 354-362. (Pubitemid 27093349)
46. Xiao GQ, Hu K, Boutjdir M. Direct inhibition of expressed cardiac l- and t-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 2001; 103: 1599-1604. (Pubitemid 32226271)
47. Ohlsson M, Gordon TP, Waterman SA. Role of anti-calcium channel and anti-receptor autoantibodies in autonomic dysfunction in Sjogren's syndrome. J Neuroimmunol 2002; 127: 127-133. (Pubitemid 34603582)
48. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201: 11-17. (Pubitemid 40130078)
49. Lazzerini PE, Capecchi PL, Acampa M, Selvi E, Guideri F, Bisogno S et al. Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: More than expected? Autoimmun Rev 2009; 9: 40-44.
50. Bourre-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P et al. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 1031-1037.
51. Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Sandberg M, Sheng Y et al. Anti-Ro52 autoantibodies from patients with Sjogren's syndrome inhibit the E3 ligase activity of Ro52 by blocking the E3:E2 interface. J Biol Chem 2011; 286: 36478-36491.
52. Bini P, Chu JL, Okolo C, Elkon K. Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome. J Clin Invest 1990; 85: 325-333. (Pubitemid 20070034)
53. Kurien BT, Scofield RH. Affinity immunoblotting for analysis of antibody clonotype distribution in a lupus patient developing anti-Ro 60 over time. Methods Mol Biol 2009; 536: 45-53.
54. Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 2008; 105: 9727-9732. (Pubitemid 352031368)
55. Elagib KE, Tengner P, Levi M, Jonsson R, Thompson KM, Natvig JB et al. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome. Arthritis Rheum 1999; 42: 2471-2481. (Pubitemid 30333428)
56. Salomonsson S, Ottosson L, Safsten P, Hof D, Brauner H, Sunnerhagen M et al. Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block. J Autoimmun 2004; 22: 167-177. (Pubitemid 38252974)
57. Lindop R, Arentz G, Chataway TK, Thurgood LA, Jackson MW, Reed JH et al. Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome. Arthritis Rheum 2011; 63: 3477-3486.
58. Wolin SL, Reinisch KM. The Ro 60kDa autoantigen comes into focus: Interpreting epitope mapping experiments on the basis of structure. Autoimmun Rev 2006; 5: 367-372. (Pubitemid 44143028)
59. Buyon JP, Clancy RM, Friedman DM. Autoimmune associated congenital heart block: Integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med 2009; 265: 653-662.
60. Ronnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011; 23: 113-121.